Sensient Technologies Corporation — Q1 2023 Form 10-Q
Business context and period: Quarterly results for the three months ended March 31, 2023, compared with the same quarter of 2022. Sensient makes flavors, extracts, ingredients, and color products. Its reportable segments are Flavors & Extracts, Color, and Asia Pacific. Figures below are in U.S. dollars; financial statement amounts are converted from thousands to millions.
Key financial results
| Metric | Q1 2023 | Q1 2022 | Change |
|---|---|---|---|
| Revenue | $369.0m | $355.5m | +3.8% reported; +5.2% local currency |
| Gross margin | 33.8% | 35.1% | Down 1.3 percentage points |
| Operating income | $50.8m | $52.8m | Down 3.7% |
| Operating margin | 13.8% | 14.8% | Down 1.0 percentage point |
| Net earnings | $33.7m | $37.1m | Down 9.2% |
| Diluted EPS | $0.80 | $0.88 | Down 9.1% reported; down 6.8% local currency |
| Interest expense | $6.0m | $3.0m | Approximately doubled |
Revenue growth was primarily due to pricing, partially offset by lower volumes; foreign exchange reduced reported revenue growth. Higher input costs and lower volumes pressured gross and operating margins, partly offset by pricing. The effective tax rate was 24.9%, versus 25.6%.
Segments
- Flavors & Extracts: Segment revenue was $178.9m, down about 2%; operating income was $22.2m, down about 20%. Lower volumes and higher raw material and manufacturing costs weighed on results.
- Color: Segment revenue was $161.2m, up about 9%; operating income was $31.9m, up about 4%. Food & Pharmaceutical Colors benefited from pricing, volumes, and the Endemix acquisition; Personal Care revenue and income declined.
- Asia Pacific: Segment revenue was $40.1m, up about 10%; operating income was $9.2m, up about 13%, supported by higher pricing and volumes. Currency effects were adverse.
Cash flow, liquidity, and debt
- Operating cash flow was negative $3.0m, compared with negative $0.9m a year earlier. Working-capital outflows included lower accrued compensation and payments in accounts payable and other accrued expenses.
- Capital expenditures were $22.3m, versus $12.7m; investing cash outflow was $22.9m. Financing provided $24.6m, including $50.8m of additional borrowings and $1.4m of debt payments. Dividends paid were $17.3m.
- Cash and cash equivalents were $24.0m at March 31, 2023, up from $20.9m at year-end. Current assets were $959.9m and current liabilities $234.7m.
- Balance-sheet short-term borrowings and long-term debt totaled $704.6m, up from $650.7m at December 31, 2022. Management attributed the increase in net debt primarily to funding capital expenditures. Interest expense increased with higher average rates and debt outstanding.
Outlook, risks, and notable items
- The filing provides no specific numerical earnings or revenue guidance. Management said operating cash flow and existing debt capacity are expected to support operations, capital spending, dividends, and potential acquisitions or repurchases. It cited notes maturing from 2023 through 2027 and expects to refinance or repay them using cash flow, additional notes, and borrowing capacity under a revolving credit facility maturing in 2026.
- Management said inflation’s impact was not material to Q1 results or financial position, but noted increased raw-material, shipping, logistics, and labor costs. Persistent or worsening inflation could pressure profitability. Other identified uncertainties include economic and geopolitical volatility, the Russia-Ukraine conflict, supply availability and costs, currency movements, customer acceptance of price increases, and execution of growth, productivity, and acquisition plans.
- The 2022 Endemix natural-colors acquisition contributed to Color; the purchase price was $23.3m cash, net of $1.3m debt assumed. Purchase accounting for certain identifiable intangible and fixed assets was still being finalized.
- Routine claims and litigation were not considered likely to have a material adverse effect based on information then available, although outcomes could affect results or cash flows in a particular period. The company reported compliance with loan covenants, effective disclosure controls, and no material changes to previously disclosed risk factors.
- Comprehensive income was $50.0m, versus $36.8m, despite lower net earnings, primarily reflecting other comprehensive income that included foreign-currency translation. The filing reports no material change in market-risk exposure.
Important facts for investors to verify
- Whether pricing continues to offset input-cost inflation and whether volumes recover, particularly in Flavors & Extracts.
- Whether the higher debt and interest burden, capital expenditures, and working-capital needs remain manageable alongside dividends and near-term debt maturities.
- How Endemix performs and whether its purchase-accounting estimates are finalized as expected.
- Whether management’s expectation that cash flow and borrowing capacity will meet anticipated needs remains supported by subsequent operating cash flow and covenant compliance.